The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022. The FDA's announcement comes months after drugmaker Novo Nordisk told the agency ...
Ozempic carries a black box warning from the FDA (the FDA’s most serious warning). It says that semaglutide has caused thyroid C-cell tumors in rodents after long-term and high dose exposure to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback